Warning: This security is no longer trading.
Company filed for Chapter 11 bankruptcy and will sell itself to Danish drugmaker Zealand Pharma
Valeritas Holdings, Inc. (VLRX): Price and Financial Metrics
Valeritas Holdings, Inc. (VLRX):
GET POWR RATINGS...
VLRX Stock Summary VLRX has a higher market value than just 2.48% of US stocks; more precisely, its current market capitalization is $5,607,102. VLRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 96.08% of US stocks. NA's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -783.9%, greater than the shareholder yield of merely 0.7% of stocks in our set. Stocks with similar financial metrics, market capitalization, and price volatility to NA are JKS, ELGX, SPNE, HEAR, and STRI.
VLRX Price/Volume Stats
Valeritas Holdings, Inc. (VLRX) Company Bio
Valeritas Holdings, a commercial-stage medical technology company, focuses on developing technologies to treat patients with Type 2 diabetes. It offers V-Go, a disposable insulin delivery device for basal-bolus therapy. The company was founded in 2006 and is based in Bridgewater, New Jersey.
VLRX Latest News Stream
All News Types
Loading, please wait...
VLRX Price Returns
Page generated in 0.8285 seconds.